Shares of Johnson & Johnson (NYS:JNJ) shed 0.60% to $167.97 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 0.20% to 4,343.54 and Dow Jones Industrial Average (DOW:DJIA) falling 0.60% to 34,577.37. The stock's fall snapped a four-day winning streak. Johnson & Johnson closed $5.68 below its 52-week high ($173.65), which the company achieved on January 26th.
Despite its losses, the stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. (OTC:RHHVF) fell 2.58% to $370.00, Merck & Co. Inc. (NYS:MRK) fell 0.62% to $78.11, and Pfizer Inc. (NYS:PFE) fell 1.11% to $39.29.true Trading volume (6.1 M) remained 513,199 below its 50-day average volume of 6.6 M.